NICE warned that potential recipients of statins need to be carefully assessed, as the drugs have potential side effects such as myopathy and ... could be eligible for treatment.

The study reviewed available evidence on safety and efficacy of statin ... of myopathy (muscle weakness) per 10,000 patients, leading to rhabdomyolysis (muscle wasting) in one patient if treatment ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

However, many current statins have major limitations. Moreover, innovative treatments need to address non-LDL-C residual risk (which may be marked by high triglycerides, low HDL-C concentrations ...

Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) are well established as treatment for lowering low-density lipoprotein cholesterol (LDL-C) and reducing cardiovascular events.